Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Short-Term Debt issuances: 2016-2023

Historic Short-Term Debt issuances for China Pharma Holdings (CPHI) over the last 1 years, with Dec 2023 value amounting to $1.0 million.

  • China Pharma Holdings' Short-Term Debt issuances was N/A to $1.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $492,761 for FY2024, which is 67.85% down from last year.
  • China Pharma Holdings' Short-Term Debt issuances amounted to $1.0 million in Q4 2023, which was up 16,850.59% from -$6,171 recorded in Q3 2023.
  • Over the past 5 years, China Pharma Holdings' Short-Term Debt issuances peaked at $3.0 million during Q3 2021, and registered a low of -$6,171 during Q3 2023.
  • In the last 2 years, China Pharma Holdings' Short-Term Debt issuances had a median value of $261,458 in 2021 and averaged $764,768.
  • Data for China Pharma Holdings' Short-Term Debt issuances shows a peak YoY increase of 292.66% (in 2021) and a maximum YoY decrease of 92.68% (in 2021) over the last 5 years.
  • China Pharma Holdings' Short-Term Debt issuances (Quarterly) stood at $160,979 in 2020, then tumbled by 92.68% to $11,790 in 2021, then reached $1.0 million in 2023.
  • Its Short-Term Debt issuances stands at $1.0 million for Q4 2023, versus -$6,171 for Q3 2023 and -$6,011 for Q2 2023.